Table 1.
All | Ovary Malignancy | Ovary Benign | p-Value | |
---|---|---|---|---|
(n = 60) | (n = 11) | (n = 49) | ||
Age, median (year) | 46 (24, 72) | 51 (32, 60) | 45 (24, 72) | 0.203 |
Breast pathology | 0.390 | |||
Invasive ductal carcinoma | 52 | 9 (81.8%) | 43 (87.8%) | |
Lobular carcinoma | 3 | 1 (9.1%) | 2 (4.1%) | |
Mucinous adenocarcinoma | 2 | 0 (0.0%) | 2 (4.1%) | |
Malignant phyllodes tumor | 1 | 0 (0.0%) | 1 (2.0%) | |
Papillary carcinoma | 1 | 0 (0.0%) | 1 (2.0%) | |
Angiosarcoma | 1 | 1 (9.1%) | 0 (0.0%) | |
Morphology | 0.000 | |||
Solid or solid-cystic | 11 | 11 (100.0%) | 1 (2.0%) | |
Cystic | 49 | 0 (0.0%) | 48 (98.0%) | |
Laterality | 0.154 | |||
Bilateral | 8 | 3 (27.3%) | 5 (10.2%) | |
Unilateral | 52 | 8 (72.7%) | 44 (89.8%) | |
Interval, median (month) | 27 (0, 140) | 8 (0, 42) | 29 (1, 140) | 0.044 |
T stage | 0.345 | |||
3–4 | 9 | 3 (27.3%) | 6 (12.2%) | |
1–2 | 51 | 8 (72.7%) | 43 (87.8%) | |
N stage | 1.000 | |||
123 | 24 | 4 (36.4%) | 20 (40.8%) | |
0 | 36 | 7 (63.6%) | 29 (59.2%) | |
M stage | 0.003 | |||
1 | 8 | 5 (45.5%) | 3 (6.1%) | |
0 | 52 | 6 (54.5%) | 46 (93.9%) |
Note—Numbers in parentheses are ranges or percentage. p-value based on Mann-Whitney test/Fisher Exact.